Healthcare provider profile · identity verified

Jodi Washinsky Lenko, MD

Hospitalist · HAZLETON, PA · NPI 1124226907

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	612	158
Atorvastatin Calcium	Atorvastatin Calcium	535	122
Rosuvastatin Calcium	Rosuvastatin Calcium	440	131
Metoprolol Succinate	Metoprolol Succinate	401	96
Simvastatin	Simvastatin	350	83
Lisinopril	Lisinopril	343	94
Amlodipine Besylate	Amlodipine Besylate	318	89
Omeprazole	Omeprazole	306	83
Losartan Potassium	Losartan Potassium	291	77
Metoprolol Tartrate	Metoprolol Tartrate	225	51
Pantoprazole Sodium	Pantoprazole Sodium	202	59
Eliquis	Apixaban	197	38
Alprazolam	Alprazolam	194	54
Metformin Hcl	Metformin Hcl	189	53
Sertraline Hcl	Sertraline Hcl	187	41
Hydrochlorothiazide	Hydrochlorothiazide	170	53
Lorazepam	Lorazepam	165	36
Escitalopram Oxalate	Escitalopram Oxalate	163	47
Furosemide	Furosemide	162	52
Jardiance	Empagliflozin	162	36
Pravastatin Sodium	Pravastatin Sodium	147	42
Clopidogrel	Clopidogrel Bisulfate	127	32
Famotidine	Famotidine	126	38
Albuterol Sulfate Hfa	Albuterol Sulfate	121	35
Tamsulosin Hcl	Tamsulosin Hcl	116	31
Gabapentin	Gabapentin	115	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	115	33
Fluticasone Propionate	Fluticasone Propionate	112	36
Allopurinol	Allopurinol	110	26
Alendronate Sodium	Alendronate Sodium	105	32
Potassium Chloride	Potassium Chloride	104	28
Celecoxib	Celecoxib	101	31
Duloxetine Hcl	Duloxetine Hcl	98	21
Meloxicam	Meloxicam	94	27
Synthroid	Levothyroxine Sodium	91	23
Mounjaro	Tirzepatide	84	16
Valsartan	Valsartan	82	22
Ozempic	Semaglutide	78	17
Citalopram Hbr	Citalopram Hydrobromide	76	21
Ezetimibe	Ezetimibe	74	20
Spironolactone	Spironolactone	72	17
Montelukast Sodium	Montelukast Sodium	69	12
Finasteride	Finasteride	67	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	66	17
Metformin Hcl Er	Metformin Hcl	65	23
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	65	13
Trazodone Hcl	Trazodone Hcl	59	18
Xarelto	Rivaroxaban	58	13
Clonazepam	Clonazepam	56	suppressed
Mirtazapine	Mirtazapine	51	12
Diclofenac Sodium	Diclofenac Sodium	50	12
Tradjenta	Linagliptin	48	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	suppressed
Torsemide	Torsemide	45	14
Carvedilol	Carvedilol	44	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	43	suppressed
Donepezil Hcl	Donepezil Hcl	42	13
Glimepiride	Glimepiride	42	suppressed
Warfarin Sodium	Warfarin Sodium	42	suppressed
Breo Ellipta	Fluticasone/Vilanterol	41	12
Trulicity	Dulaglutide	41	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Farxiga	Dapagliflozin Propanediol	38	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Ibuprofen	Ibuprofen	36	17
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	36	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Aripiprazole	Aripiprazole	33	suppressed
Diazepam	Diazepam	31	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Enalapril Maleate	Enalapril Maleate	30	suppressed
Prednisone	Prednisone	30	20
Lansoprazole	Lansoprazole	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	26
Cephalexin	Cephalexin	28	17
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	28	18
Azithromycin	Azithromycin	27	24
Colchicine	Colchicine	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Bumetanide	Bumetanide	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	23
Tramadol Hcl	Tramadol Hcl	25	13
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Atenolol	Atenolol	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	15
Myrbetriq	Mirabegron	23	suppressed
Nystatin	Nystatin	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Nitroglycerin	Nitroglycerin	19	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	19	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Propranolol Hcl	Propranolol Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	12
Cilostazol	Cilostazol	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Glipizide	Glipizide	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Repaglinide	Repaglinide	17	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	16	suppressed
Flecainide Acetate	Flecainide Acetate	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Risperidone	Risperidone	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Vascepa	Icosapent Ethyl	16	suppressed
Amoxicillin	Amoxicillin	15	11
Baclofen	Baclofen	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Buprenorphine	Buprenorphine	15	suppressed
Klor-Con M10	Potassium Chloride	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Cyclosporine	Cyclosporine	13	suppressed
Dilantin	Phenytoin Sodium Extended	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Methimazole	Methimazole	12	suppressed
Neurontin	Gabapentin	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Nitroglycerin Patch	Nitroglycerin	12	suppressed
Tegretol	Carbamazepine	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Humalog Kwikpen U-200	Insulin Lispro	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error